Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Condition: Seasonal Allergic RhinitisInterventions: Drug: Desloratadine 5 mg; Drug: PlaceboSponsor: Merck Sharp & Dohme Corp.Active, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials